Kemadrin

Designed to target Parkinson’s to address movement control.

Strengths: 5mg

Medicine details

Therapeutic class

Antimuscarinic

Pharmacological class

Antimuscarinic

Contraindications

angle-closure glaucoma; pyloric stenosis; prostatic hypertrophy

Precautions and warnings

may impair ability to drive

Minor side effects

dry mouth; blurred vision

Moderate side effects

constipation; nausea

Dosage forms

Tablet

Administration route

Oral use

Patient summary

Designed to target Parkinson’s to address movement control.

Prescription status

POM

Manufacturer

Aspen Pharmacare

Onset Time

15–30 minutes

Duration

4–6 hours

Storage instructions

Store below 25°C.

Drug interactions

antipsychotics; alcohol

Age restrictions

Caution in elderly patients.

Serious side effects

psychosis — requires immediate medical attention; confusion — requires immediate medical attention

Mechanism of action

Kemadrin acts as a centrally acting anticholinergic agent that helps restore the balance between acetylcholine and dopamine in the basal ganglia, improving motor function.

Pregnancy and breastfeeding

Pregnancy: Use only under close medical supervision. Breastfeeding: Consult physician.

Kemadrin

Designed to target Parkinson’s to address movement control.

Editorial Notes

  • Active ingredient(s): Procyclidine
  • Listed indication(s): Parkinsonism, Drug-induced Extrapyramidal Symptoms

Available option

  • 120 tablets - 5 mg162-5-mg-3315